UB Paderborn / Katalog / Suche / in CDI

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

JAMA cardiology, 2024-04, Vol.9 (4), p.323

2024

Volltextzugriff (PDF)

Assessing HIV Care Outcomes Among Persons Who Use Drugs in Puerto Rico Before and After Hurricane Maria

Disaster medicine and public health preparedness, 2023-05, Vol.17, p.e397-e397, Article e397

2023

Volltextzugriff (PDF)

Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk

Clinical infectious diseases, 2022-09, Vol.75 (7), p.1154-1163

2022

Volltextzugriff (PDF)

Associations Between Blood Pressure Variability, Salt Intake, Physical Activity, And Sedentary Time In HIV+ Hispanics: 1345

Medicine and science in sports and exercise, 2021-08, Vol.53 (8S), p.442-442

2021

Volltextzugriff (PDF)

Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy

The Journal of infectious diseases, 2020-07, Vol.222 (4), p.601-610

2020

Volltextzugriff (PDF)

Public Health Academic Alliance for COVID-19 Response: The Role of a National Medical Task Force in Puerto Rico

International journal of environmental research and public health, 2020-07, Vol.17 (13), p.4839

2020

Volltextzugriff (PDF)

Mechanical Efficiency After High Intensity Interval Training In Hiv+ Hispanic Women: 1986 Board #142 May 30 3:30 PM - 5:00 PM

Medicine and science in sports and exercise, 2019-06, Vol.51 (6 Suppl), p.533-533

2019

Volltextzugriff (PDF)

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

The lancet HIV, 2018-05, Vol.5 (5), p.e211-e220

2018

Volltextzugriff (PDF)

The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico

BMC health services research, 2017-03, Vol.17 (1), p.232-232, Article 232

2017

Volltextzugriff (PDF)

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy

The Journal of infectious diseases, 2016-02, Vol.213 (4), p.556-560

2016

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

The New England journal of medicine, 2015-08, Vol.373 (8), p.705-713

2015

Volltextzugriff (PDF)

Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257

Clinical infectious diseases, 2015-06, Vol.60 (12), p.1842-1851

2015

Volltextzugriff (PDF)

Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s

Journal of acquired immune deficiency syndromes (1999), 2015-06, Vol.69 (2), p.168-177

2015

Volltextzugriff (PDF)

Metabolic syndrome in relation to cardiorespiratory fitness, active and sedentary behavior in HIV+ Hispanics with and without lipodystrophy

Puerto Rico health sciences journal, 2014-12, Vol.33 (4), p.163-169

2014

Volltextzugriff (PDF)

METABOLIC SYNDROME IN RELATION TO CARDIORESPIRATORY FITNESS, ACTIVE AND SEDENTARY BEHAVIOR IN HIV+ HISPANICS WITH AND WITHOUT LIPODYSTROPHY: Fitness and Metabolic-Syndrome in HIV

Puerto Rico health sciences journal, 2014-12, Vol.33 (4), p.163-169

2014

Volltextzugriff (PDF)

Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229

AIDS (London), 2010-10, Vol.24 (16), p.2507-2515

2010

Volltextzugriff (PDF)

AIDS Clinical Trials Group 5197: A Placebo-Controlled Trial of Immunization of HIV-1-Infected Persons with a Replication-Deficient Adenovirus Type 5 Vaccine Expressing the HIV-1 Core Protein

The Journal of infectious diseases, 2010-09, Vol.202 (5), p.705-716

2010

Volltextzugriff (PDF)

Comparison of Once-Daily versus Twice-Daily Combination Antiretroviral Therapy in Treatment-Naive Patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48-Week Randomized Controlled Trial

Clinical infectious diseases, 2010-04, Vol.50 (7), p.1041-1052

2010

Volltextzugriff (PDF)

Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial

Archives of internal medicine (1960), 2009-07, Vol.169 (13), p.1224

2009

Volltextzugriff (PDF)

Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC®: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry

Journal of antimicrobial chemotherapy, 2008-12, Vol.62 (6), p.1392-1400

2008

Volltextzugriff (PDF)

A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)

The Journal of infectious diseases, 2006-12, Vol.194 (12), p.1672-1676

2006

Volltextzugriff (PDF)

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleuldn-2 cycles to promote efficient control of viral replication (ACTG A5024)

The Journal of infectious diseases, 2006, Vol.194 (12), p.1672-1676

2006

Volltextzugriff (PDF)

Physical and Leisure Activity, Body Composition, and Life Satisfaction in HIV-Positive Hispanics in Puerto Rico

The Journal of the Association of Nurses in AIDS Care, 2004-07, Vol.15 (4), p.68-77

2004

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

Assessing HIV Care Outcomes Among Persons Who Use Drugs in Puerto Rico Before and After Hurricane Maria

Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk

Associations Between Blood Pressure Variability, Salt Intake, Physical Activity, And Sedentary Time In HIV+ Hispanics: 1345

Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy

Public Health Academic Alliance for COVID-19 Response: The Role of a National Medical Task Force in Puerto Rico

Mechanical Efficiency After High Intensity Interval Training In Hiv+ Hispanic Women: 1986 Board #142 May 30 3:30 PM - 5:00 PM

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257

Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s

Metabolic syndrome in relation to cardiorespiratory fitness, active and sedentary behavior in HIV+ Hispanics with and without lipodystrophy

METABOLIC SYNDROME IN RELATION TO CARDIORESPIRATORY FITNESS, ACTIVE AND SEDENTARY BEHAVIOR IN HIV+ HISPANICS WITH AND WITHOUT LIPODYSTROPHY: Fitness and Metabolic-Syndrome in HIV

Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229

AIDS Clinical Trials Group 5197: A Placebo-Controlled Trial of Immunization of HIV-1-Infected Persons with a Replication-Deficient Adenovirus Type 5 Vaccine Expressing the HIV-1 Core Protein

Comparison of Once-Daily versus Twice-Daily Combination Antiretroviral Therapy in Treatment-Naive Patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48-Week Randomized Controlled Trial

Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial

Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC®: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry

A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleuldn-2 cycles to promote efficient control of viral replication (ACTG A5024)

Physical and Leisure Activity, Body Composition, and Life Satisfaction in HIV-Positive Hispanics in Puerto Rico

Suchergebnisse filtern